Y10S977/773

Nanoencapsulation of hydrophilic active compounds

Provided is a nanoparticle including a water-soluble protein, a glucan and a hydrophilic active agent, the glucan being at least partially cross-linked by a metaphosphate.

Electrodes, lithium-ion batteries, and methods of making and using same

Described herein are improved composite anodes and lithium-ion batteries made therefrom. Further described are methods of making and using the improved anodes and batteries. In general, the anodes include a porous composite having a plurality of agglomerated nanocomposites. At least one of the plurality of agglomerated nanocomposites is formed from a dendritic particle, which is a three-dimensional, randomly-ordered assembly of nanoparticles of an electrically conducting material and a plurality of discrete non-porous nanoparticles of a non-carbon Group 4A element or mixture thereof disposed on a surface of the dendritic particle. At least one nanocomposite of the plurality of agglomerated nanocomposites has at least a portion of its dendritic particle in electrical communication with at least a portion of a dendritic particle of an adjacent nanocomposite in the plurality of agglomerated nanocomposites.

Novel Liposome Nanoparticles for Tumor Magnetic Resonance Imaging

The present invention provides novel liposomes comprising Gd.DOTA.DSA (gadolinium (III) 2-{4,7-bis-carboxymethyl-10-[(N,N-distearylamidomethyl-N′-amido-methyl]-1,4,7,10-tetra-azacyclododec-1-yl}-acetic acid), characterised in that said liposome further comprises a neutral, fully saturated phospholipid component (e.g. DSPC (1,2-distearoyl-sn-glycero-3-phospocholine]), which are of particular use in the preparation of magnetic resonance contrast agents for enhancing a magnetic resonance image of tumours in a mammal.

Liposomes Useful for Drug Delivery

The present invention provides liposome compositions containing substituted ammonium and/or polyanion, and optionally with a desired therapeutic or imaging entity. The present invention also provide methods of making the liposome compositions provided by the present invention.

Titanium dioxide photocatalytic compositions and uses thereof

Provided is a photocatalytic composition comprising zinc (Zn) doped titanium dioxide (TiO.sub.2) nanoparticles, wherein the ratio of titanium dioxide nanoparticles to zinc is from about 5 to about 150. The photocatalytic composition absorbs electromagnetic radiation in a wavelength range from about 200 nm to about 500 nm, and the absorbance of light of wavelengths longer than about 450 nm is less than 50% the absorbance of light of wavelengths shorter than about 350 nm.

Core-shell nanoparticles comprising same element of different isotopes

A core-shell nanoparticle is provided that includes a core comprising a first isotope of an element; an isolation layer surrounding the core; and a shell layer surrounding the isolation layer, wherein the shell layer comprises a second isotope of the element, with the first isotope being different than the second isotope. Methods are also provided for forming such core-shell nanoparticles.

GRAPHENE METAL NANOPARTICLE-COMPOSITE
20170341939 · 2017-11-30 ·

The present disclosure relates to a method of preparing a graphene metal nanoparticle-composite, including: preparing graphene by applying a shearing force to a first solution containing a graphite-based material and thus exfoliating the graphite-based material; preparing metal nanoparticles by applying a shearing force to a second solution containing a metal precursor, a capping agent, and a reducing agent; and physically combining the metal nanoparticles on the graphene by applying a shearing force to a third solution containing the graphene and the metal nanoparticles, and a graphene metal nanoparticle-composite prepared according to the method.

Method for carrying therapeutic substances into cells

The present invention relates to compositions containing nanoparticies and uses of said composition for transferring therapeutically active substances into cells by means of specifically coated nanoparticles. The chemical design of the particles is such that a large amount thereof is absorbed into the cells. No direct bond between nanoparticle and the therapeutically active substance is required for the transfer into the cells. Thanks to said transfer, an increased efficacy of the substance and simultaneously reduced systemic toxicity is achieved, i.e. an increase in the efficacy while the side effects are reduced.

Metal-enhanced photoluminescence from carbon nanodots
09829436 · 2017-11-28 · ·

The present invention relates to enhancement of detectable emissions from carbon nanodots or variants thereof by using the techniques of MEF to further enhance carbon nanodot brightness, photostability, and thus, potentially detectability in biological imaging applications by using plasmon supporting materials, such as silver island films and positioning of the carbon nanodots an optimal distance from the plasmon supporting materials.

Nanostructured inorganic electrode materials with functionalized surfaces
11670767 · 2023-06-06 ·

Embodiments of inorganic electrode materials that utilize nanostructure surface modifications via functionalization via carbonate/carboxylate to achieve superior electrochemical performance and methods of producing same.